Ziopharm Oncology (ZIOP) Announces Publication of Positive CAR T Cell Data in Targeting Solid Tumor Cells
Tweet Send to a Friend
Ziopharm Oncology (NASDAQ: ZIOP) announced the publication of a preclinical study in Cancer Research, a journal of the American Association ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
